Over the last few weeks, the pace of developments in non-communicable disease (NCD) news has been heady. So much is happening it is hard even for those of us in the NCD community to keep up. But even in the midst of so much news, one item stood out head and shoulders above the rest:… Read More

This post was written by Nalini Saligram, PhD, founder and CEO of Arogya World. On Earth Day, we generally tend to focus on the impact of people on the planet. But it is equally important to consider the impact of pollution on people and health including non-communicable diseases (NCDs). NCDs, which include cardiovascular disease, diabetes,… Read More

Mother’s Day is fast approaching, and provides members and supporters of organizations such as ours with an opportunity to reflect on the role of mothers in disease prevention. As we’ve discussed in this space before (and surely will again), the world is at a tipping point. Non-communicable diseases (NCDs) such as diabetes, cardiovascular disease, cancer,… Read More

Our guest blogger, Carol Teutsch, M.D., is an endocrinologist who practiced in Atlanta for 20 years, caring for and learning from many women patients. She worked at a pharmaceutical company in the Philadelphia area for many years and now works in Los Angeles to bring health literacy programs to vulnerable families in the U.S. Twenty… Read More

CSIS held a blog contest on NCDs asking authors to answer the question “What should the key priority of the upcoming UN High Level Meeting on Non-Communicable Diseases be and why?”  This is an excellent way to mobilize the NCD community and we thank the CSIS for hosting the contest.  Our entry, republished below, was… Read More

A news report in The Times of India from earlier this month disclosed some significant news – it said that India’s Prime Minister, Mr. Manmohan Singh, is planning to attend the UN Summit on NCDs in New York on September 19th. This kind of engagement from heads of state is vital to ensure the summit’s… Read More

The NCD Alliance, by far the largest civil society group working to maximize the impact of the UN Summit on NCDs (Non-Communicable Diseases), has just released a document that articulates 34 “asks” from the UN and countries around the world, which if adopted, can make the UN Summit on NCDs on September 19 and 20,… Read More

Arogya World’s first guest blogger, Jeffrey Meer, is the Special Advisor of Global Health Policy and Development at The Public Health Institute. He conducts PHI’s Washington-based advocacy on global health, and provides strategic direction for the organization’s participation in global health procurements by the United States Government and private donors. This year is an important… Read More

Co-authored by Nalini Saligram, founder and CEO of Arogya World, and Jill Sheffield, founder and President of Women Deliver, this op-ed was also published on The Huffington Post. There are times in the history of the world when the actions of people with foresight and wisdom have averted crises on a mass scale. We are… Read More

Arogya World has received funding from Merck for its Diabetes Awareness and Prevention Education program in India’s schools. This support will allow Arogya World to educate 11-14-year-old school children through teacher- and peer-led classroom activities about diabetes and its complications, as well as how this serious disease could be prevented through increased physical activity and healthy eating habits.

The program will be piloted in some of Delhi’s schools through a partnership between Arogya World and youth NGO HRIDAY-SHAN, adapting their successful school-based tobacco control model for diabetes education, using credible authority figures like teachers and peer-leaders to teach the benefits of healthy living to young children before their lifestyle habits are set. According to Arogya World founder Nalini Saligram, “Non-profit organizations like ours cannot do the work we want to do without the support of sponsors and partners. This is important work, at the core of our diabetes prevention offering in India, and we are so pleased we can begin implementation with support from Merck.”